XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2

SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2022

Defined Benefit Plan Disclosure [Line Items]

SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW

Cash and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated Statements of Cash Flows as follows:

SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW 

		June 30, 2022				June 30, 2021
Cash		$	2,979,769			$	6,348,415
Restricted cash			1,417,635				484,350
Total cash and restricted cash		$	4,397,404			$	6,832,765

SCHEDULE OF EARN OUT LIABILITY

SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT 

		June 30, 2022				December 31, 2021
Stock price		$	2.11			$	6.44
Volatility			105	%			90	%
Time to expiry			4.51				5
Dividend yield			0	%			0	%
Risk free rate			3.00	%			1.10	%

SCHEDULE OF RECONCILES WARRANT COMMITMENT

The following reconciles fair value of the liability classified warrants:

SCHEDULE OF RECONCILES WARRANT COMMITMENT 

			Series B Warrant Commitment				Series B warrant liabilities				Placement agent warrants			Total
		Three and Six Months ended June 30, 2022
		Series B Warrant Commitment				Series B warrant liabilities				Placement agent warrants				Total
Beginning balance		$	37,652,808			$	-			$	-			$	37,652,808
Initial recognition			-				55,061,119				1,525,923				56,587,042
Unrealized (gain) loss			17,408,311				(31,980,437	)			(946,461	)			(15,518,587	)
Warrants exercised or transferred			(55,061,119	)											(55,061,119	)
Ending balance, March 31, 2022		$	-			$	23,080,682			$	579,462			$	23,660,144
Unrealized gain			-				(12,322,737	)			(310,514	)			(12,633,251	)
Ending balance, June 30, 2022			-				10,757,945				268,948				11,026,893

			Series B Warrant Commitment				Total
		December 31, 2021
		Series B Warrant Commitment				Total
Beginning balance		$	-			$	-
Initial recognition			20,244,497				20,244,497
Unrealized gain			17,408,311				17,408,311
Ending balance		$	37,652,808			$	37,652,808

SCHEDULE OF FAIR VALUE MEASUREMENTS

SCHEDULE OF FAIR VALUE MEASUREMENTS 

		June 30, 2022				December 31, 2021
Valuation technique			Discounted cash flow				Discounted cash flow
Significant unobservable input			Projected revenue and probability of achievement				Projected revenue and probability of achievement

SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE

SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE 

		June 30, 2022				December 31, 2021
Beginning balance – January 1		$	3,813,878			$	2,931,418
Acquisitions and Settlements
JP Kush Acquisition			-				1,694,166
Barra Acquisition			600,000				-
CCS Write-off			-				(81,368	)
Altruis partial settlement			(84,473	)			(452,236	)
Montana final settlement			(326,935	)			-
Period adjustments:
Fair value changes and accretion included in earnings*			354,963				(278,102	)
Ending balance		$	4,357,433			$	3,813,878
Less: Current portion			(3,683,596	)			(3,297,855	)
Ending balance, less current portion			673,837				516,023

* Recorded as a reduction to general and administrative expenses

SCHEDULE OF DISAGGREGATION REVENUE

The following table disaggregates the Company’s revenue by line of business, showing commissions earned:

 SCHEDULE OF DISAGGREGATION REVENUE

Three Months ended June 30, 2022		Medical/Life				Property and Casualty				Total
Regular
EBS		$	184,851			$	-			$	184,851
USBA			12,319				-				12,319
CCS/UIS			-				57,195				57,195
Montana			451,705				-				451,705
Fortman			357,334				205,804				563,138
Altruis			882,171				-				882,171
Kush			425,449				-				425,449
Medigap			1,359,976				-				1,359,976
Barra			69,925				200,397				270,322
		$	3,743,730			$	463,396			$	4,207,126

Six Months ended June 30, 2022		Medical/Life				Property and Casualty				Total
Regular
EBS		$	406,035			$	-			$	406,035
USBA			25,906				-				25,906
CCS/UIS			-				101,077				101,077
Montana			958,426				-				958,426
Fortman			689,933				403,064				1,092,997
Altruis			2,187,043				-				2,187,043
Kush			864,040				-				864,040
Medigap			2,537,061				-				2,537,061
Barra			69,925				200,397				270,322
		$	7,738,369			$	704,538			$	8,442,907

Three Months ended June 30, 2021		Medical/Life				Property and Casualty				Total
Regular
EBS			207,201				-				207,201
USBA			15,395				-				15,395
CCS/UIS			-				65,348				65,348
Montana			404,740				-				404,740
Fortman			276,634				226,337				502,971
Altruis			729,874				-				729,874
Kush			265,318				-				265,318
		$	1,899,162			$	291,685			$	2,190,847

Six Months ended June 30, 2021		Medical/Life				Property and Casualty				Total
Regular
EBS		$	416,195			$	-			$	416,195
USBA			27,620				-				27,620
CCS/UIS			-				154,166				154,166
Montana			939,856				-				939,856
Fortman			526,435				434,109				960,544
Altruis			1,750,878				-				1,750,878
Kush			265,318				-				265,318
		$	3,926,302			$	588,275			$	4,514,577

SCHEDULE OF CONCENTRATIONS OF REVENUES

The following, are customers representing 10% or more of total revenue:

SCHEDULE OF CONCENTRATIONS OF REVENUES 

Insurance Carrier		2022				2021
		For the three months ended June 30,
Insurance Carrier		2022				2021
LTC Global			30	%			-	%
Priority Health			20	%			31	%
BlueCross BlueShield			-	%			28	%

Insurance Carrier		2022				2021
		For the six months ended June 30,
Insurance Carrier		2022				2021
BlueCross BlueShield			10	%			25	%
Priority Health			25	%			33	%
LTC Global			28	%			-	%

SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION

SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION 

Account		12/31/2020 As reported				Adjustment				12/31/2020 Adjusted
Earn-out liability			2,631,418				300,000				2,931,418
Goodwill			9,265,070				(503,345	)			8,761,725
Common stock issuable			822,116				(482,116	)			340,000
Additional paid-in-capital			11,377,123				182,116				11,559,239
Accumulated Deficit			(12,482,281	)			122,601				(12,359,680	)

Account		3/31/2021 As reported				Adjustment				3/31/2021   Adjusted
Common stock issuable			482,116				(482,116	)			0
Additional paid-in-capital			25,810,147				182,116				25,992,263
Accumulated Deficit			(13,123,609	)			150,003				(12,973,606	)

Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

SCHEDULE OF EARN OUT LIABILITY

The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs:

 SCHEDULE OF EARN OUT LIABILITY

		June 30, 2022
WACC Risk Premium:			14.6	%
Volatility			50	%
Credit Spread:			11	%
Payment Delay (days)			90	%
Risk free rate			USD Yield Curve
Discounting Convention:			Mid-period
Number of Iterations			100,000

X

- Definition

Schedule of reconciles warrant commitment [Table Text Block]

+ References

No definition available.

+ Details

Name:	RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock
Namespace Prefix:	RELI_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DefinedBenefitPlanDisclosureLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1)(a))
-URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910

+ Details

Name:	us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 16
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: